Dengue - 67 Studies Found Completed : Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus Vaccine : Dengue : 2007-05-11 : Biological: rDEN1delta30 Live Completed : Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults : Dengue : 2006-05-04 : Biological: rDEN4delta30-4995 Completed : Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults : Dengue : 2006-09-12 : Biological: rDEN3/4delta30(ME) Completed : Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection : Dengue Fever : 2008-05-28 : Other: case/control case: infected dengue fever people control:healthy people Completed : Role of Andi-d in Dengue Fever: a Pilot Study : Dengue Fever : 2011-09-25 : Drug: anti-d intervention group received injection anti-d in dose of 50 µg/kg (250IU/kg) along with Not yet recruiting : Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore : Dengue Fever : 2015-10-01 : Drug: Celgosivir Celgosivir 15 Completed : Diagnosis and Characterization of Dengue Fever in Children : Dengue Fever : 2009-07-22 Completed : Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou : Dengue Fever : 2015-10-11 Active, not recruiting : A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) : Dengue Fever : 2012-10-04 : Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant Active, not recruiting : A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults : Dengue Fever : 2012-08-08 : Biological: 4 µg TDENV-PIV with Alum adjuvant <<< Previous | Next >>>
